Offer - Urjas Oil for just ₹ 1 X
Brimochek T is a prescription drug, available for use as Drops. Other than this, Brimochek T has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Brimochek T is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Brimochek T are Eye Burning, Eye irritation, Stinging in the Eyes. Some other side effects of Brimochek T have been listed ahead. Usually, these side effects of Brimochek T go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Brimochek T's effect during pregnancy is Mild and Unknown while nursing. Further, the section on Brimochek T related warnings talks about Brimochek T's effects on the liver, heart and kidney.
Brimochek T is contraindicated in people with pre-existing medical conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. The section on Brimochek T contraindications lists all such conditions.
Additionally, Brimochek T may also adversely react with other medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Brimochek T is considered safe while driving, and is addictive.
Brimochek T is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Brimochek T safe for pregnant women?
Brimochek T has mild to no side effects in pregnant women.
Is the use of Brimochek T safe during breastfeeding?
There is no research available on the side effects of Brimochek T in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Brimochek T on the Kidneys?
Brimochek T can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Brimochek T on the Liver?
Brimochek T can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Brimochek T on the Heart?
The heart can be affected by Brimochek T. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Brimochek T should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Brimochek T unless your doctor advises you to do so -
Is this Brimochek T habit forming or addictive?
No, there is no any evidence that Brimochek T is addictive.
Interaction between Food and Brimochek T
Taking Brimochek T with food is safe.
Interaction between Alcohol and Brimochek T
No research has been done on this till date. Therefore, it is not known what the effect of taking Brimochek T with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)